The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation

Cell

Volumn 123, Issue 3, 2005, Pages 409-421

  Adhikary, Sovana ^a   Marinoni, Federica ^b   Hock, Andreas ^a   Hulleman, Esther ^b   Popov, Nikita ^a   Beier, Rudi ^a   Bernard, Sandra ^a   Quarto, Micaela ^c   Capra, Maria ^c   Goettig, Stephan ^a   Kogel, Ulrike ^e   Scheffner, Martin ^e   Helin, Kristian ^b,d   Eilers, Martin ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

E3 UBIQUITIN LIGASE HECTH9; MYC PROTEIN; ONCOPROTEIN; PROTEIN P300; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPATHOLOGY; EMBRYO; ENZYME REGULATION; GENE SWITCHING; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR CELL; UBIQUITINATION;

ANIMALIA;

EID: 27544473311     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2005.08.016     Document Type: Article

References (32)

1. S. Adhikary, and M. Eilers Transcriptional regulation and transformation by Myc proteins Nature Rev Mol Biol 6 2005 635 645
2. V.J. Bardwell, and R. Treisman The POZ domain: A conserved protein-protein interaction motif Genes Dev. 8 1994 1664 1677
3. T. Berg, S.B. Cohen, J. Desharnais, C. Sonderegger, D.J. Maslyar, J. Goldberg, D.L. Boger, and P.K. Vogt Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts Proc. Natl. Acad. Sci. USA 99 2002 3830 3835
4. V. Bres, R.E. Kiernan, L.K. Linares, C. Chable-Bessia, O. Plechakova, C. Treand, S. Emiliani, J.M. Peloponese, K.T. Jeang, and O. Coux A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter Nat. Cell Biol. 5 2003 754 761
5. T.R. Brummelkamp, R. Bernards, and R. Agami Stable suppression of tumorigenicity by virus-mediated RNA interference Cancer Cell 2 2002 243 247
6. D. Chen, N. Kon, M. Li, W. Zhang, J. Qin, and W. Gu ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor Cell 121 2005 1071 1083
7. A. Datta, A. Nag, W. Pan, N. Hay, A.L. Gartel, O. Colamonici, Y. Mori, and P. Raychaudhuri Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc J. Biol. Chem. 279 2004 36698 36707
8. R.N. Eisenman Deconstructing myc Genes Dev. 15 2001 2023 2030
9. A. Ferdous, F. Gonzalez, L. Sun, T. Kodadek, and S.A. Johnston The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II Mol. Cell 7 2001 981 991
10. K. Flick, I. Ouni, J.A. Wohlschlegel, C. Capati, W.H. McDonald, J.R. Yates, and P. Kaiser Proteolysis-independent regulation of the transcription factor Met4 by a single Lys 48-linked ubiquitin chain Nat. Cell Biol. 6 2004 634 641
11. S.R. Frank, T. Parisi, S. Taubert, P. Fernandez, M. Fuchs, H.M. Chan, D.M. Livingston, and B. Amati MYC recruits the TIP60 histone acetyltransferase complex to chromatin EMBO Rep. 4 2003 575 580
12. J. Gu, K. Ren, R. Dubner, and M.J. Iadarola Cloning of a DNA binding protein that is a tyrosine kinase substrate and recognizes an upstream initiator-like sequence in the promoter of the preprodynorphin gene Brain Res. Mol. Brain Res. 24 1994 77 88
13. S. Herold, M. Wanzel, V. Beuger, C. Frohme, D. Beul, T. Hillukkala, J. Syvaoja, H.P. Saluz, F. Hänel, and M. Eilers Negative regulation of the mammalian UV response by Myc through association with Miz-1 Mol. Cell 10 2002 509 521
14. J.M. Huibregtse, M. Scheffner, S. Beaudenon, and P.M. Howley A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase Proc. Natl. Acad. Sci. USA 92 1995 2563 2567
15. M. Jain, C. Arvanitis, K. Chu, W. Dewey, E. Leonhardt, M. Trinh, C.D. Sundberg, J.M. Bishop, and D.W. Felsher Sustained loss of a neoplastic phenotype by brief inactivation of MYC Science 297 2002 102 104
16. P. Kaiser, K. Flick, C. Wittenberg, and S.I. Reed Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4 Cell 102 2000 303 314
17. S.Y. Kim, A. Herbst, K.A. Tworkowski, S.E. Salghetti, and W.P. Tansey Skp2 regulates myc protein stability and activity Mol. Cell 11 2003 1177 1188
18. J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, G. Sauter, and O.P. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat. Med. 4 1998 844 847
19. L. Kuras, A. Rouillon, T. Lee, R. Barbey, M. Tyers, and D. Thomas Dual regulation of the met4 transcription factor by ubiquitin-dependent degradation and inhibition of promoter recruitment Mol. Cell 10 2002 69 80
20. L.K. Linares, A. Hengstermann, A. Ciechanover, S. Muller, and M. Scheffner HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53 Proc. Natl. Acad. Sci. USA 100 2003 12009 12014
21. J.P. Morgenstern, and H. Land Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line Nucleic Acids Res. 18 1990 3587 3596
22. E.I. Rugarli, B. Lutz, S.C. Kuratani, S. Wawersik, G. Borsani, A. Ballabio, and G. Eichele Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting Nat. Genet. 4 1993 19 26
23. S.E. Salghetti, S.Y. Kim, and W.P. Tansey Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc EMBO J. 18 1999 717 726
24. M. Schuhmacher, F. Kohlhuber, M. Holzel, C. Kaiser, H. Burtscher, M. Jarsch, G.W. Bornkamm, G. Laux, A. Polack, U.H. Weidle, and D. Eick The transcriptional program of a human B cell line in response to Myc Nucleic Acids Res. 29 2001 397 406
25. L.T. Vassilev, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, and C. Klein In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 303 2004 844 848
26. J. Vervoorts, J.M. Luscher-Firzlaff, S. Rottmann, R. Lilischkis, G. Walsemann, K. Dohmann, M. Austen, and B. Luscher Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP EMBO Rep. 4 2003 1 7
27. N. von der Lehr, S. Johansson, S. Wu, F. Bahram, A. Castell, C. Cetinkaya, P. Hydbring, I. Weidung, K. Nakayama, and K.I. Nakayama The F-Box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription Mol. Cell 11 2003 1189 1200
28. W. Walker, Z.Q. Zhou, S. Ota, A. Wynshaw-Boris, and P.J. Hurlin Mnt-Max to Myc-Max complex switching regulates cell cycle entry J. Cell Biol. 169 2005 405 413
29. M. Welcker, A. Orian, J. Jin, J.A. Grim, J.W. Harper, R.N. Eisenman, and B.E. Clurman The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation Proc. Natl. Acad. Sci. USA 101 2004 9085 9090
30. M.A. Wood, S.B. McMahon, and M.D. Cole An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc Mol. Cell 5 2000 321 330
31. M. Yada, S. Hatakeyama, T. Kamura, M. Nishiyama, R. Tsunematsu, H. Imaki, N. Ishida, F. Okumura, K. Nakayama, and K.I. Nakayama Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7 EMBO J. 23 2004 2116 2125
32. E. Yeh, M. Cunningham, H. Arnold, D. Chasse, T. Monteith, G. Ivaldi, W.C. Hahn, P.T. Stukenberg, S. Shenolikar, and T. Uchida A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells Nat. Cell Biol. 6 2004 308 318